Literature DB >> 17914192

Exploiting dendritic cells for active immunotherapy of cancer and chronic infections.

David W O'Neill1, Nina Bhardwaj.   

Abstract

Dendritic cells (DCs) are important antigen-presenting cells (APCs) that can prime naive T cells and control adaptive immune responses with respect to magnitude, memory and self-tolerance. Understanding the biology of these cells is central to the development of new generation immunotherapies for cancer and chronic infections. This review presents a brief overview of DC biology and of the preparation and use of DC-based vaccines.

Entities:  

Mesh：

Substances：

Year:  2007        PMID： 17914192     DOI： 10.1007/s12033-007-0020-6

Source DB:  PubMed          Journal:  Mol Biotechnol        ISSN： 1073-6085            Impact factor:   2.695


  152 in total

1.  Linking innate and adaptive immunity.

Authors:  K Palucka; J Banchereau
Journal:  Nat Med       Date:  1999-08       Impact factor: 53.440

Review 2.  Scavenger receptors in innate immunity.

Authors:  Leanne Peiser; Subhankar Mukhopadhyay; Siamon Gordon
Journal:  Curr Opin Immunol       Date:  2002-02       Impact factor: 7.486

Review 3.  Dendritic cells: specialized and regulated antigen processing machines.

Authors:  I Mellman; R M Steinman
Journal:  Cell       Date:  2001-08-10       Impact factor: 41.582

Review 4.  C-type lectin receptors on dendritic cells and Langerhans cells.

Authors:  Carl G Figdor; Yvette van Kooyk; Gosse J Adema
Journal:  Nat Rev Immunol       Date:  2002-02       Impact factor: 53.106

Review 5.  Toll-like receptors in the induction of the innate immune response.

Authors:  A Aderem; R J Ulevitch
Journal:  Nature       Date:  2000-08-17       Impact factor: 49.962

Review 6.  A fresh look at tumor immunosurveillance and immunotherapy.

Authors:  M J Smyth; D I Godfrey; J A Trapani
Journal:  Nat Immunol       Date:  2001-04       Impact factor: 25.606

Review 7.  How dendritic cells and microbes interact to elicit or subvert protective immune responses.

Authors:  Karolina Palucka; Jacques Banchereau
Journal:  Curr Opin Immunol       Date:  2002-08       Impact factor: 7.486

8.  Immunology. CD8 T cells remember with a little help.

Authors:  Susan M Kaech; Rafi Ahmed
Journal:  Science       Date:  2003-04-11       Impact factor: 47.728

Review 9.  Cancer immunoediting: from immunosurveillance to tumor escape.

Authors:  Gavin P Dunn; Allen T Bruce; Hiroaki Ikeda; Lloyd J Old; Robert D Schreiber
Journal:  Nat Immunol       Date:  2002-11       Impact factor: 25.606

10.  Cross-priming of naive CD8 T cells against melanoma antigens using dendritic cells loaded with killed allogeneic melanoma cells.

Authors:  F Berard; P Blanco; J Davoust; E M Neidhart-Berard; M Nouri-Shirazi; N Taquet; D Rimoldi; J C Cerottini; J Banchereau; A K Palucka
Journal:  J Exp Med       Date:  2000-12-04       Impact factor: 14.307
View more
  7 in total

1.  Nitric oxide controls an inflammatory-like Ly6C(hi)PDCA1+ DC subset that regulates Th1 immune responses.

Authors:  Daniela Giordano; Chang Li; Mehul S Suthar; Kevin E Draves; Daphne Y Ma; Michael Gale; Edward A Clark
Journal:  J Leukoc Biol       Date:  2010-12-22       Impact factor: 4.962

Review 2.  In vivo imaging of immune cell trafficking in cancer.

Authors:  Luisa Ottobrini; Cristina Martelli; Daria Lucia Trabattoni; Mario Clerici; Giovanni Lucignani
Journal:  Eur J Nucl Med Mol Imaging       Date:  2010-12-18       Impact factor: 9.236

3.  High-efficiency transduction of human monocyte-derived dendritic cells by capsid-modified recombinant AAV2 vectors.

Authors:  George V Aslanidi; Angela E Rivers; Luis Ortiz; Lakshmanan Govindasamy; Chen Ling; Giridhara R Jayandharan; Sergei Zolotukhin; Mavis Agbandje-McKenna; Arun Srivastava
Journal:  Vaccine       Date:  2012-04-10       Impact factor: 3.641

4.  Chemotherapeutic agents in noncytotoxic concentrations increase antigen presentation by dendritic cells via an IL-12-dependent mechanism.

Authors:  Galina V Shurin; Irina L Tourkova; Ramon Kaneno; Michael R Shurin
Journal:  J Immunol       Date:  2009-06-17       Impact factor: 5.422

5.  Lymphoid-tissue-specific homing of bone-marrow-derived dendritic cells.

Authors:  Rémi J Creusot; Shahriar S Yaghoubi; Pearl Chang; Justine Chia; Christopher H Contag; Sanjiv S Gambhir; C Garrison Fathman
Journal:  Blood       Date:  2009-04-10       Impact factor: 22.113

6.  A randomized therapeutic vaccine trial of canarypox-HIV-pulsed dendritic cells vs. canarypox-HIV alone in HIV-1-infected patients on antiretroviral therapy.

Authors:  Rajesh T Gandhi; David O'Neill; Ronald J Bosch; Ellen S Chan; R Pat Bucy; Janet Shopis; Lynn Baglyos; Elizabeth Adams; Lawrence Fox; Lynette Purdue; Ann Marshak; Theresa Flynn; Reena Masih; Barbara Schock; Donna Mildvan; Sarah J Schlesinger; Mary A Marovich; Nina Bhardwaj; Jeffrey M Jacobson
Journal:  Vaccine       Date:  2009-05-29       Impact factor: 3.641

7.  Autologous tumor lysate-pulsed dendritic cell immunotherapy with cytokine-induced killer cells improves survival in gastric and colorectal cancer patients.

Authors:  Daiqing Gao; Changyou Li; Xihe Xie; Peng Zhao; Xiaofang Wei; Weihong Sun; Hsin-Chen Liu; Aris T Alexandrou; Jennifer Jones; Ronghua Zhao; Jian Jian Li
Journal:  PLoS One       Date:  2014-04-03       Impact factor: 3.240
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.